Small Interfering RNA (siRNA) Therapeutics Market Set to Surge as Precision Gene-Silencing Treatments Gain Momentum Small Interfering RNA (siRNA) Therapeutics Market is rapidly transitioning into a cornerstone of next-generation medicine, with the market expected to reach around USD 39.19 billion by 2032, driven by the rising incidence of genetic and chronic diseases, and accelerating...

The RNA analysis market is entering a strong growth phase as transcriptomic research, precision medicine, drug discovery, and RNA-based therapeutics increase demand for advanced molecular analysis. The market was valued at USD 9.2 billion in 2025 and is projected to grow from USD 9.9 billion in 2026 to USD 23.6 billion by 2033, registering a 13.3% CAGR from 2026 to 2033. The expansion reflects...